Halving fertility treatment costs could double births globally
Reducing the cost of fertility treatments by half could more than double the number of births, according to a major global study presented at the 42nd ESHRE Annual Meeting.
A significant international study suggests that halving the expenses for fertility treatments could lead to more than double the number of births. The findings were presented at the 42nd Annual Meeting of the European Society of Human Reproduction and Embryology (ESHRE).
The research indicated that by identifying the most effective treatments for women with a Body Mass Index (BMI) below 25, the average cost of treatment could decrease from approximately £10,000 to £5,000. This cost reduction, coupled with targeted therapeutic approaches, could potentially increase birth rates by a factor of 11 to 14, compared to a mere doubling without these changes.
This study highlights the potential impact of cost accessibility on fertility outcomes. By making treatments more affordable, a larger number of individuals could pursue necessary interventions, thereby contributing to a potential rise in global birth rates.
The findings underscore the need for healthcare providers and policymakers to re-evaluate current cost structures and treatment protocols. The goal is to enhance the accessibility of assisted reproductive technologies for a broader patient population.